Maravai Historical Financial Ratios

MRVI Stock

USD 5.66 0.11 1.91%

Maravai Lifesciences is lately reporting on over 101 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 45.78 will help investors to properly organize and evaluate Maravai Lifesciences financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

About Maravai Financial Ratios Analysis

Maravai LifesciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Maravai Lifesciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Maravai financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Maravai Lifesciences history.

Maravai Lifesciences Financial Ratios Chart

As of now, Maravai Lifesciences' Capex To Depreciation is increasing as compared to previous years. The Maravai Lifesciences' current Inventory Turnover is estimated to increase to 3.83, while Price To Sales Ratio is projected to decrease to 2.84.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding Cash Conversion Cycle

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Maravai Lifesciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Maravai Lifesciences sales, a figure that is much harder to manipulate than other Maravai Lifesciences Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Maravai Lifesciences Holdings dividend as a percentage of Maravai Lifesciences stock price. Maravai Lifesciences dividend yield is a measure of Maravai Lifesciences stock productivity, which can be interpreted as interest rate earned on an Maravai Lifesciences investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from Maravai Lifesciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Maravai Lifesciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

	2023	2024 (projected)
Dividend Yield	0.0176	0.0157
Price To Sales Ratio	2.99	2.84

Dividend Yield Price To Sales Ratio

Maravai Lifesciences fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		0.6	0.66	-0.71	-0.92	-0.77	-0.83	0.21	-0.81	0.66	1.0	-0.73	-0.54	0.71	-0.48	-0.61	-0.36	-0.58	-0.94	-0.87	-0.55	-0.6	-0.86	-0.73	0.21	-0.17
Dividend Yield	0.6		0.69	-0.15	-0.64	-0.16	-0.13	0.89	-0.79	0.69	0.59	0.05	0.21	0.23	0.31	-0.09	0.24	-0.89	-0.33	-0.45	0.2	-0.81	-0.46	-0.38	-0.2	0.23
Ptb Ratio	0.66	0.69		-0.25	-0.88	-0.59	-0.44	0.37	-0.48	1.0	0.66	-0.34	-0.21	0.06	-0.11	0.09	0.07	-0.54	-0.57	-0.4	-0.33	-0.7	-0.4	-0.31	-0.05	0.15
Days Sales Outstanding	-0.71	-0.15	-0.25		0.52	0.57	0.56	0.15	0.58	-0.25	-0.7	0.52	0.32	-0.8	0.32	0.8	0.48	0.37	0.77	0.63	0.35	0.51	0.63	0.52	-0.33	0.31
Book Value Per Share	-0.92	-0.64	-0.88	0.52		0.8	0.77	-0.23	0.66	-0.88	-0.92	0.67	0.52	-0.44	0.43	0.31	0.22	0.53	0.86	0.71	0.58	0.63	0.71	0.58	-0.14	0.07
Free Cash Flow Yield	-0.77	-0.16	-0.59	0.57	0.8		0.9	0.22	0.34	-0.59	-0.77	0.88	0.71	-0.34	0.7	0.28	0.63	0.11	0.8	0.62	0.86	0.17	0.62	0.52	-0.41	0.27
Operating Cash Flow Per Share	-0.83	-0.13	-0.44	0.56	0.77	0.9		0.27	0.41	-0.44	-0.84	0.98	0.89	-0.58	0.87	0.52	0.59	0.08	0.9	0.74	0.9	0.1	0.73	0.63	-0.39	0.33
Average Payables	0.21	0.89	0.37	0.15	-0.23	0.22	0.27		-0.58	0.37	0.2	0.44	0.58	-0.04	0.64	0.13	0.37	-0.78	0.12	-0.14	0.56	-0.61	-0.15	-0.12	-0.29	0.3
Capex To Depreciation	-0.81	-0.79	-0.48	0.58	0.66	0.34	0.41	-0.58		-0.48	-0.8	0.25	0.05	-0.62	-0.02	0.56	-0.05	0.92	0.62	0.85	0.01	0.78	0.85	0.8	0.21	-0.22
Pb Ratio	0.66	0.69	1.0	-0.25	-0.88	-0.59	-0.44	0.37	-0.48		0.66	-0.34	-0.21	0.06	-0.11	0.09	0.07	-0.54	-0.57	-0.4	-0.33	-0.7	-0.4	-0.31	-0.05	0.15
Ev To Sales	1.0	0.59	0.66	-0.7	-0.92	-0.77	-0.84	0.2	-0.8	0.66		-0.73	-0.55	0.71	-0.49	-0.62	-0.36	-0.58	-0.94	-0.86	-0.56	-0.6	-0.86	-0.73	0.22	-0.17
Free Cash Flow Per Share	-0.73	0.05	-0.34	0.52	0.67	0.88	0.98	0.44	0.25	-0.34	-0.73		0.94	-0.52	0.94	0.49	0.63	-0.1	0.85	0.65	0.96	-0.04	0.63	0.54	-0.44	0.39
Roic	-0.54	0.21	-0.21	0.32	0.52	0.71	0.89	0.58	0.05	-0.21	-0.55	0.94		-0.43	0.99	0.41	0.48	-0.29	0.73	0.49	0.94	-0.21	0.47	0.41	-0.35	0.35
Inventory Turnover	0.71	0.23	0.06	-0.8	-0.44	-0.34	-0.58	-0.04	-0.62	0.06	0.71	-0.52	-0.43		-0.4	-0.98	-0.42	-0.32	-0.75	-0.63	-0.28	-0.39	-0.62	-0.48	0.39	-0.47
Net Income Per Share	-0.48	0.31	-0.11	0.32	0.43	0.7	0.87	0.64	-0.02	-0.11	-0.49	0.94	0.99	-0.4		0.4	0.56	-0.37	0.68	0.45	0.95	-0.32	0.44	0.38	-0.4	0.39
Days Of Inventory On Hand	-0.61	-0.09	0.09	0.8	0.31	0.28	0.52	0.13	0.56	0.09	-0.62	0.49	0.41	-0.98	0.4		0.42	0.25	0.68	0.6	0.25	0.29	0.59	0.48	-0.36	0.44
Payables Turnover	-0.36	0.24	0.07	0.48	0.22	0.63	0.59	0.37	-0.05	0.07	-0.36	0.63	0.48	-0.42	0.56	0.42		-0.33	0.41	0.16	0.59	-0.27	0.15	0.01	-0.89	0.82
Capex To Revenue	-0.58	-0.89	-0.54	0.37	0.53	0.11	0.08	-0.78	0.92	-0.54	-0.58	-0.1	-0.29	-0.32	-0.37	0.25	-0.33		0.34	0.62	-0.29	0.88	0.63	0.6	0.41	-0.44
Cash Per Share	-0.94	-0.33	-0.57	0.77	0.86	0.8	0.9	0.12	0.62	-0.57	-0.94	0.85	0.73	-0.75	0.68	0.68	0.41	0.34		0.8	0.71	0.47	0.8	0.67	-0.28	0.26
Pocfratio	-0.87	-0.45	-0.4	0.63	0.71	0.62	0.74	-0.14	0.85	-0.4	-0.86	0.65	0.49	-0.63	0.45	0.6	0.16	0.62	0.8		0.46	0.46	1.0	0.97	0.14	-0.18
Interest Coverage	-0.55	0.2	-0.33	0.35	0.58	0.86	0.9	0.56	0.01	-0.33	-0.56	0.96	0.94	-0.28	0.95	0.25	0.59	-0.29	0.71	0.46		-0.2	0.45	0.38	-0.42	0.35
Payout Ratio	-0.6	-0.81	-0.7	0.51	0.63	0.17	0.1	-0.61	0.78	-0.7	-0.6	-0.04	-0.21	-0.39	-0.32	0.29	-0.27	0.88	0.47	0.46	-0.2		0.47	0.38	0.22	-0.23
Capex To Operating Cash Flow	-0.86	-0.46	-0.4	0.63	0.71	0.62	0.73	-0.15	0.85	-0.4	-0.86	0.63	0.47	-0.62	0.44	0.59	0.15	0.63	0.8	1.0	0.45	0.47		0.97	0.15	-0.19
Pfcf Ratio	-0.73	-0.38	-0.31	0.52	0.58	0.52	0.63	-0.12	0.8	-0.31	-0.73	0.54	0.41	-0.48	0.38	0.48	0.01	0.6	0.67	0.97	0.38	0.38	0.97		0.33	-0.37
Days Payables Outstanding	0.21	-0.2	-0.05	-0.33	-0.14	-0.41	-0.39	-0.29	0.21	-0.05	0.22	-0.44	-0.35	0.39	-0.4	-0.36	-0.89	0.41	-0.28	0.14	-0.42	0.22	0.15	0.33		-0.98
Income Quality	-0.17	0.23	0.15	0.31	0.07	0.27	0.33	0.3	-0.22	0.15	-0.17	0.39	0.35	-0.47	0.39	0.44	0.82	-0.44	0.26	-0.18	0.35	-0.23	-0.19	-0.37	-0.98

Click cells to compare fundamentals

Maravai Lifesciences Account Relationship Matchups

Maravai Lifesciences fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	20.15	9.54	6.02	2.13	2.99	2.84
Ptb Ratio	20.4	30.63	15.24	3.45	2.07	1.97
Days Sales Outstanding	45.98	65.55	53.67	60.69	70.39	45.78
Book Value Per Share	1.5	1.6	4.75	6.88	5.99	6.29
Free Cash Flow Yield	0.002415	0.0468	0.0735	0.28	0.0702	0.0623
Operating Cash Flow Per Share	0.25	1.57	3.21	4.07	0.96	1.34
Stock Based Compensation To Revenue	0.0117	0.0867	0.0131	0.0211	0.12	0.13
Capex To Depreciation	0.71	0.98	0.6	0.45	1.34	1.41
Pb Ratio	20.4	30.63	15.24	3.45	2.07	1.97
Ev To Sales	22.71	10.79	6.0	2.08	3.12	2.96
Free Cash Flow Per Share	0.0721	1.31	3.08	3.94	0.46	0.44
Roic	0.0445	0.1	0.58	0.48	0.007535	0.007158
Inventory Turnover	4.71	2.39	2.73	3.92	2.89	3.83
Net Income Per Share	(0.0538)	0.8	4.09	3.73	(0.9)	(0.86)
Days Of Inventory On Hand	77.54	152.61	133.88	93.22	126.12	89.24
Payables Turnover	8.94	26.68	17.24	28.2	13.86	14.9
Research And Ddevelopement To Revenue	0.0253	0.0327	0.019	0.0208	0.0598	0.0628
Capex To Revenue	0.12	0.0894	0.0186	0.0194	0.23	0.24
Cash Per Share	0.26	2.44	4.8	4.81	4.36	2.26
Pocfratio	119.63	17.81	13.05	3.51	6.85	7.19
Interest Coverage	0.8	2.2	18.33	28.13	(0.69)	(0.66)
Capex To Operating Cash Flow	0.71	0.17	0.0403	0.0319	0.52	0.55
Pfcf Ratio	414.08	21.38	13.6	3.63	14.24	14.95
Days Payables Outstanding	40.83	13.68	21.17	12.94	26.33	25.05
Income Quality	(4.64)	1.93	0.79	1.09	(1.06)	(1.01)
Roe	(0.0368)	0.87	1.49	0.9	(0.29)	(0.27)
Ev To Operating Cash Flow	134.79	20.14	13.0	3.42	7.13	7.49
Pe Ratio	(554.68)	35.26	10.25	3.84	(7.26)	(7.62)
Ev To Free Cash Flow	466.54	24.18	13.55	3.54	14.84	15.58
Earnings Yield	(0.001803)	0.0284	0.0976	0.26	(0.14)	(0.13)
Intangibles To Total Assets	0.73	0.32	0.14	0.22	0.37	0.47
Net Debt To E B I T D A	7.58	2.56	(0.029)	(0.0768)	0.0505	0.048
Current Ratio	2.05	2.54	7.89	7.7	8.0	8.4
Tangible Book Value Per Share	(2.87)	(2.56)	2.4	3.08	1.84	1.93
Receivables Turnover	7.94	5.57	6.8	6.01	5.19	7.19
Graham Number	1.33	4.05	15.9	18.65	8.01	6.75
Shareholders Equity Per Share	1.46	0.92	2.75	4.14	3.16	1.87
Debt To Equity	2.39	6.04	1.68	0.97	1.26	1.19

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:

How To Invest In Maravai

Details

Is Maravai Stock a good investment?

Details

What is Maravai Lifesciences' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.33)

Earnings Share

(1.67)

Revenue Per Share

2.044

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.02)

The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Maravai Historical Financial Ratios

About Maravai Financial Ratios Analysis

Maravai Lifesciences Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Maravai Lifesciences fundamentals Correlations

Maravai Lifesciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Maravai Lifesciences fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Capex To Operating Cash Flow	+ 1.0	Pocfratio
Net Income Per Share	+ 0.99	Roic
Free Cash Flow Per Share	+ 0.98	Operating Cash Flow Per Share
Pfcf Ratio	+ 0.97	Pocfratio

Income Quality	- 0.98	Days Payables Outstanding
Days Of Inventory On Hand	- 0.98	Inventory Turnover
Cash Per Share	- 0.94	Ev To Sales
Cash Per Share	- 0.94	Price To Sales Ratio
Ev To Sales	- 0.92	Book Value Per Share
Book Value Per Share	- 0.92	Price To Sales Ratio